As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags

GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy rank among the biggest medical breakthroughs in years, owing to their efficacy in treating obesity and type 2 diabetes, and reducing the risk of heart disease. Some 10 million Americans used them last year, a figure that could grow to 25 million by 2030, according to JPMorgan research.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Wr3mxLu
via